MedPath
NMPA Approval

复方救必应胶囊

国药准字Z44022270

September 16, 2019

Drug Information

复方救必应胶囊

白云山

胶囊剂

中药

September 16, 2019

Company Information

Manufacturing Company

广州市沙太北路389号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方救必应胶囊 - NMPA 批准文号 | MedPath